Still, as mentioned, plenty of people with PCOS have overlap with conditions GLP-1s are approved for, namely diabetes or obesity
Then in an announcement on Tuesday, the drugmaker unveiled that the National Medical Products Administration (NMPA), Chinas top drug regulator, had allowed the injection to be used in weight reduction, making it the first GLP-1 receptor agonist officially available in the country for people who wish to lose weight but for diabetes-unrelated reasons
Insurance Coverage and Prescribing Guidelines GLP-1 medications such as Ozempic, Wegovy, and Mounjaro are now approved for long-term use in maintaining weight loss after an initial reduction phase
it is not available through the NHS or any regulated UK pharmacy and remains in clinical development
Recommended USA Supply Choose your region Use discount code Save15 at Nura Peptides checkout